Dividends at Risk in 2026: The Sector Map of Thin Coverage

Heading into the second half of 2026, income investors keep circling the same two questions: which dividends are genuinely at risk this year, and where is coverage thinnest. Start with the scale of it, because the headlines can mislead. This is not a market-wide wave of cuts. S&P Dow Jones Indices expects S&P 500 dividend payments to grow at a mid-single-digit pace in 2026, and its analyst Howard Silverblatt has warned against assuming those raises will be generous. Across all of 2025, only 176 US-listed issues reduced a dividend, against 2,293 that raised one. Cuts happen, but they are the exception. The question worth asking is where the cushion has worn thinnest, and what is wearing it down.

Three pressures are doing most of that wearing in 2026. Interest rates that have stayed high are meeting a wall of debt that has to be refinanced. The consumer is soft and uneven. And a handful of sectors carry their own specific stress, usually from leverage or heavy capital spending. This piece maps where those pressures land hardest, sector by sector, and shows you how to read the same signals for yourself. One thing to hold onto throughout: these are readings of a moment, not forecasts. A company with thin-looking coverage often keeps paying for years. Calling these names "unsafe dividend stocks for 2026" is screening shorthand, not a verdict on any of them. Every figure here is current as of June 5, 2026, and the dividendscut.com scores quoted are from our May 12-13 snapshot, flagged as our own reading alongside the public numbers.

The 2026 risk map, at a glance

Read each row as a reason to look closer, not a conclusion. Every one of these companies has either raised its dividend recently or is improving operationally, which is exactly why the headline number on its own will fool you.

Why 2026 is different

The rate backdrop is the structural pressure sitting under the whole map. At its meeting on April 28 and 29, 2026, the Federal Reserve held its target range at 3.50% to 3.75%, drawing four dissents, the most at a single meeting since October 1992. The vote on the rate itself was 11 to 1, with Governor Stephen Miran preferring a cut, while the other three dissents were about the easing bias in the statement rather than the decision to hold. The message was persistence. Debt borrowed cheaply in the 2010s and again in 2020 and 2021 now has to be rolled over at much higher rates. Two maturity figures often get confused here. Roughly $936 billion of commercial real estate loans come due in 2026, heavily weighted toward office, while S&P Global puts total US corporate maturities near $3 trillion. A loan struck at 3% or 4% that refinances near 6% or 7% swallows more cash flow at precisely the moment leverage matters most. That is why leveraged REITs and capital-heavy issuers sit higher on this map. It is structural pressure rather than a trigger.

The second pressure is the consumer, who is still spending but carefully. Real consumer-spending growth is expected to slow toward roughly 1.5% in 2026. The Census Bureau's advance estimate had retail sales slipping about 0.1% in January before a February rebound, soft and tilted toward discretionary goods rather than anything resembling a collapse. Deloitte's spring work on the US consumer actually shows discretionary spending intentions rising for a second straight month after a March dip, which is the reminder that the consumer is uneven, not falling off a cliff. The strain shows up most in consumer cyclicals and at the lower end of staples. The third pressure is tariffs, and the clearest example is Whirlpool, which has guided to about 175 basis points of negative margin impact, including the Section 232 changes announced in April 2026. That is a direct squeeze on the cash a dividend depends on, and it is the one spot on this map where the question has already been answered.

How to read coverage yourself

This is the plain-English version of the four dimensions our score blends, and three signals do most of the work.

The first is a payout ratio above 100% of earnings, which means the dividend is larger than reported profit. Before reading anything into it, check whether the distortion is non-cash. Amortization and acquired research charges can crush reported earnings without touching the cash that actually pays the dividend, which is exactly what happens at AbbVie. So a payout over 100% is a prompt to investigate, not a conclusion.

The second is free cash flow coverage below one times, meaning the company's free cash flow didn't fully fund the dividend that period. The thing to work out is whether that is seasonal, or a matter of capex timing, or structural, a deficit that runs for years, as it did at Whirlpool.

The third is rising net debt relative to EBITDA, which narrows a company's room to maneuver, especially when its debt has to be refinanced into higher rates. A payout that looks fine on cash flow can become the swing variable the moment a balance sheet has to be defended.

REITs need a different yardstick. Because depreciation makes a REIT's earnings-based payout almost meaningless, you swap EPS for AFFO or FFO. On that basis, roughly 70% to 85% is healthy, and anything above about 90% is where it starts to look stretched. Our nightly score runs this same four-part read across hundreds of US stocks.

The cautionary tale: Whirlpool

Whirlpool is the contrast that makes the rest of the map readable, because for Whirlpool the question is no longer open. In May 2026 the company suspended its common dividend, the first halt in 55 years, redirecting cash to pay down more than $900 million of debt maturing in 2026 and cutting its full-year adjusted-earnings guidance to a range of $3.00 to $3.50. In our own data the score had been sitting at 4 out of 10 before the suspension, and the suspension forced it to 1. By our own calculation, laid out in the standalone article, fiscal 2025 free cash flow of roughly $92 million stood against about $299 million in dividends, with net debt above 6 times EBITDA. We flag those last two as our derived numbers rather than single filing lines, since published free-cash-flow figures vary by method. The signals were flashing well before the board acted. The score reflected the stress; it didn't predict the decision. This is the one place on the map where we can speak plainly, because the suspension is a fact.

Pharma: patent cliffs and the cash-versus-earnings trap

Pfizer, which our score flags at 3 out of 10, is the thin-cash-coverage case. In fiscal 2025 its dividends of $9.771 billion came in about $695 million above its free cash flow of $9.076 billion. The GAAP payout was roughly 126.5%, the adjusted-earnings payout about 53.4%, and the yield runs somewhere around 6.4% to 6.7%. Behind those numbers is a patent problem, with something like $17 billion to $18 billion of revenue exposed across 2026 to 2028 as Eliquis and Xeljanz lose US protection. On cash, the dividend is roughly covered and slightly short. The other side carries weight, though. Chief executive Albert Bourla has said Pfizer intends to "maintain and over time grow" the dividend, which has now risen for 16 straight years, and the June 12, 2026 payment is the company's 350th consecutive quarterly dividend. Management's fiscal 2026 adjusted-earnings guidance of $2.80 to $3.00 keeps the adjusted payout comfortably under 65%, and the Motley Fool's read is that the odds of a cut this year are low. We don't offer a forecast of our own.

AbbVie, at 5 out of 10, is the best teaching case on this page that a payout ratio read carelessly will mislead you. Its trailing GAAP payout of roughly 285% looks alarming until you see what it is made of, which is amortization and research charges from the company's post-Humira acquisition spree, not a cash signal. On free cash flow the payout is about 59.6% as of late May 2026, and AbbVie just raised its quarterly dividend to $1.73, up 5.5% from $1.64, extending a 52-year run of increases. Humira itself has rolled over, falling to $688 million in the first quarter of 2026 from a peak near $21 billion, but Skyrizi at about $4.483 billion and Rinvoq at about $2.119 billion in the quarter have already more than replaced it. Full-year 2025 revenue set a record near $61 billion, and free cash flow covers the dividend with room to spare.

Consumer: soft demand against thin coverage

Starbucks, at 3 out of 10, declared a $0.62 quarterly dividend payable on May 29, 2026, backed by 15 straight years of increases. On its second-quarter release, first-half operating cash flow of $1,962.2 million less $596.4 million of capex left roughly $1,365.8 million of free cash flow against $1,411.4 million in dividends paid, so coverage for the half ran about 0.97 times. Simply Wall St, working on a different basis, reports the dividend as covered by neither earnings, where it sees a payout near 204%, nor cash flow, where it sees around 121%, which is why we name the metric and the source rather than quote one number as if it were settled. The case on the other side is strong. The "Back to Starbucks" turnaround is showing up in the figures, with second-quarter global comparable sales up 6.2%, revenue up 9% to $9.5 billion, GAAP earnings of $0.45 a share up 32%, and full-year guidance raised to a non-GAAP range of $2.25 to $2.45. An earnings trough like this is the kind a recovery mechanically repairs.

PepsiCo, at 5 out of 10, just announced its 54th consecutive annual increase, which makes it a Dividend King, with a roughly 4% raise starting from the June 2026 payment. Its first quarter, the twelve weeks ended March 21, is the seasonal low point for cash: operating cash flow was only $41 million against $447 million of capex, a negative free-cash-flow quarter that looks like a coverage failure in isolation but is really working-capital timing. Across full-year 2025 the company generated roughly $8.2 billion of free cash flow, from $12,087 million of operating cash flow less $4,415 million of capex plus $528 million of asset sales, comfortably covering the $7,638 million it paid in dividends. Even against the roughly $7.9 billion of dividends planned for 2026, full-year coverage works out near 96%. A 54-year King with cash flows this diversified treats its dividend as close to untouchable. The "$10 billion" PepsiCo figure that circulates is its new buyback authorization running through February 2030, not free cash flow.

Campbell's sits outside our snapshot, and we cover it in a dedicated piece. The short version: a yield above 7% on a frozen $0.39 payout, stretched to roughly 71% forward and 85% trailing, with leverage near 3.7 times, but free cash flow still covering the dividend about 1.5 times. That last point is the counterweight that lands it in the double-check range.

Energy and utilities: when one bad quarter isn't a verdict

Chevron, at 5 out of 10, raised its quarterly dividend about 4% to $1.78, payable June 10, 2026, extending a streak of roughly 39 years. Its trailing earnings payout near 104% is an artifact of the cyclical trough in 2025 oil prices, not a sign the dividend has outrun the business. The instructive part is the first-quarter cash flow. Reported free cash flow was negative $1,549 million, from $2,514 million of operating cash flow against $4,063 million of capex, while the company paid $3,526 million in dividends. That reads as stress until you see that adjusted free cash flow was a positive $4,127 million, the gap driven by working-capital outflows tied to March's swing in commodity prices, with net debt at a modest 1.3 times operating cash flow. Energy dividends have to be read on free cash flow across a full cycle, not on reported earnings in one heavy-spending quarter.

Utilities belong on this page as context rather than distress. The country's investor-owned utilities have laid out roughly $1.4 trillion of capital spending through 2030 to feed demand from AI data centers, which is why post-capex free cash flow at regulated names like Duke, Southern Company and NextEra reads negative. For a regulated utility that is normal, funded through a familiar mix of debt and equity, and not the warning sign it would be at an unregulated company running a deficit. NextEra's roughly $67 billion agreement on May 18, 2026 to acquire Dominion is a growth move, not a sign of strain.

REITs and the GAAP-versus-AFFO lesson

REITs are where the headline payout misleads most often. The names facing the hardest refinancing math carry net debt above roughly 6 times EBITDA with maturities in 2026 and 2027, and office is the stressed corner, the same commercial-real-estate wall described earlier. The genuine distress cluster combines an AFFO payout above 90%, a near-term maturity wall, and a yield above 8%, and several office REITs have already trimmed or restructured their payouts. That is a description of the sector, not a call on any single name.

The cleanest illustration of why earnings-based payouts mislead is a false signal in our own data, Realty Income. In the snapshot it surfaces as a GAAP-versus-AFFO artifact, a known quirk rather than a finding, so we don't present it as at-risk. By Realty Income's own first-quarter 2026 release, monthly dividends were 71.7% of diluted AFFO of $1.13 a share, and the $3.246 annualized dividend against full-year AFFO guidance of $4.41 to $4.44 implies that same low-70s payout. The dividend is soundly covered. It is the proof, in our own numbers, that a scary headline payout can be completely misleading, the same lesson AbbVie teaches on the pharma side.

What it comes down to

None of the names on this map have cut their dividend. What they share is a stretched headline number sitting next to a real counterweight, and the only way to tell a temporary squeeze from a structural break is to read the four signals together rather than reacting to one. Where they point the same direction, as they did at Whirlpool for months before the board acted, the picture is worth taking seriously. Where they don't, a frightening payout ratio is often just accounting.

dividendscut.com sends you an email the moment a US dividend is cut, suspended, or eliminated, and scores every stock from 1 to 10 each night on the same four signals used here. Pro runs $29 a month with a 14-day free trial and no card required. See also how to be alerted to dividend cuts and the retail dividend information gap.

A note on sourcing

Figures are current as of June 5, 2026. The dividendscut.com scores quoted (Pfizer 3, AbbVie 5, Starbucks 3, PepsiCo 5, Chevron 5) come from our May 12-13, 2026 snapshot and are flagged as our own reading alongside the public numbers. Sources include the SEC filings and investor releases of Pfizer, AbbVie, Starbucks, PepsiCo, Chevron and Realty Income; the Federal Reserve's April 29, 2026 implementation note and CNBC's coverage of that meeting; S&P Dow Jones Indices' January 2026 dividend report; S&P Global on corporate maturities; the Census Bureau's advance retail-sales release and Deloitte's State of the US Consumer work; Whirlpool's first-quarter 2026 earnings call; and CNBC on the NextEra and Dominion agreement. Third-party readings, from Simply Wall St on Starbucks and the Motley Fool on Pfizer, are attributed as such, and the Whirlpool free-cash-flow and leverage figures are our own calculations, detailed in the standalone article. This is educational, not investment advice, and not a prediction of any company's actions.

Common questions

Which dividends look most at risk in 2026? On a four-part read of payout, cash flow, leverage and track record, the thinnest-coverage large caps as of June 5, 2026 include Pfizer, Starbucks, Chevron, PepsiCo and AbbVie. Each pairs a stretched headline figure with a real counterweight, whether a recent raise, a long streak, or improving results, so treat the list as a starting point for research rather than a set of predictions.

How can I tell if a dividend is safe? Read four things together: the payout ratio, free cash flow coverage, net debt to EBITDA, and how long the company has paid and raised. Judge whether they point the same way. A payout above 100% of earnings is worth investigating, but check first whether the distortion is non-cash, as it is with AbbVie's roughly 285% GAAP payout against a 59.6% free-cash-flow payout. For REITs, use AFFO instead of earnings, where above about 90% is the worry line.

Can a stock with thin coverage keep paying? Routinely. Realty Income's healthy 72% AFFO payout despite a misleading earnings-based headline, and PepsiCo's 54-year streak running straight through a negative-cash-flow quarter, both show that thin-looking coverage is not the same as a coming cut. A high yield is often just the market flagging uncertainty. None of the names here have cut, and we make no prediction that any will.